Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 2003

View Archived Issues

Interaction of unfractionated heparin and aspirin with YM-337 after infusion in healthy subjects

ViroPharma presents three series of antipicornavirus agents

Cathepsin K inhibitors under study at Novartis

Novel PPARalpha agonists identified by Aventis researchers

Merck presents new tyrosine kinase inhibitors for cancer and other angiogenesis-related disorders

Solvay claims new NK2 antagonists with utility in irritable bowel syndrome therapy

Alizyme scientists describe novel lipase inhibitors for obesity and related disorders

Grant supports development of CEL-1000 for viral encephalitis

Insulin detemir offers improved predictability and control in basal bolus insulin therapy

Second phase I study of OGX-011 begins

Elidel approved in Switzerland

Approvable letter for Vitrase

HE-2100 protects nonhuman primates from effects of radiation exposure

Epimmune's EP HIV-1090 vaccine candidate taken into phase I trials

Recent findings on angiolytic Exherin

Obese patients enrolled in new phase IIb trial for BVT-933

Frovatriptan launched in U.K.

FDA approves Factive for respiratory tract infections

Protein Design Labs completes acquisition of Eos Biotechnology

Rat studies with AZD-3582 indicate good efficacy and GI tolerability

Pharmacokinetic/pharmacodynamic modeling for proton pump inhibitor YH-1885

Chymase inhibitor shows potential in preventing aortic aneurysmal dilatation

Successful treatment of fibromyalgia with tizanidine

Improvement in metabolic syndrome upon chronic treatment with adenosine receptor antagonist

Better safety profile found for etoricoxib compared to indomethacin in acute gouty arthritis

SAR reported at ACS meeting in a series of ranolazine analogues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...